MEDICINES RECONCILIATION FOR PAEDIATRIC PATIENTS ON ADMISSION AND DISCHARGE

Maria Moss1, Celine Bilbul1, Jo Crook1

  • 1Chelsea and Westminster NHS Foundation Trust.

Insights

Medicines reconciliation (MR) for paediatric patients fell short of national standards, highlighting a need for improved processes. Timely documentation and pharmacist involvement are crucial for reducing medication errors in children.

Area of Science:

  • Paediatric Pharmacy Practice
  • Medication Safety
  • Healthcare Quality Improvement

Background:

  • National guidance emphasizes accurate medicines reconciliation (MR) to reduce medication errors during care transitions.
  • Current MR guidelines exclude children under 16, a group at higher risk due to off-label and unlicensed formulations.
  • Paediatric patients require specific attention to ensure safe medication management.

Purpose of the Study:

  • To quantitatively assess the level of medicines reconciliation for paediatric inpatients.
  • To evaluate the timeliness of medication history documentation and reconciliation on admission and discharge.
  • To determine if discharge summaries are sent to General Practitioners (GPs) promptly.

Main Methods:

  • Retrospective audit of paediatric take-home prescriptions over two weeks.
  • Utilized an electronic prescribing system for data collection on MR processes.
  • Employed Qualtrics software for data entry and Microsoft Excel for analysis.

Main Results:

  • Only 49.2% of patients had drug history documented within 24 hours of admission.
  • 60.0% of patients had medicines reconciled by a pharmacist within 72 hours of admission.
  • 70.8% had medicines reconciled at discharge, and 87.7% had discharge summaries sent to GPs within 24 hours.

Conclusions:

  • None of the four audited standards for paediatric medicines reconciliation were met.
  • Identified a need for more medicines reconciliation technicians and improved out-of-hours support.
  • Emphasized the necessity of multidisciplinary team collaboration and enhanced pharmacist understanding of MR processes.
Abstract

Keywords:
AbstractOral

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
682
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312